secwatch.observer — SEC 8-K summary
======================================

Issuer:     BillionToOne, Inc. (BLLN)
CIK:        0002070849
Form:       8-K
Filed at:   2026-08-05T20:25:27+00:00
Accession:  0002070849-26-000048
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BillionToOne Q2 revenue $109.4M (+64% YoY); net income $8.1M; reiterates FY guidance $450-465M
--------------------------------------------------------------------------------

- Revenue $109.4M (+64% YoY); prenatal $94.2M (+55%), oncology $13.7M (+176%).
- Gross margin 70% (vs 65%); operating income $5.5M vs loss of $1.6M; net income $8.1M ($0.15 EPS).
- 196,000 tests delivered (+35%); free cash flow $5.1M.
- Reiterates FY2026 revenue guidance $450M-$465M (48-52% growth).
- Announces expanded Unity Fetal Risk Screen (130-gene panel) and Northstar Origin launch.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2070849/000207084926000048/0002070849-26-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2070849/000207084926000048/blln-20260805.htm
  HTML page:      https://secwatch.observer/filing/0002070849-26-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer